Literature DB >> 34319489

The Function and Regulation of Platelet P2Y12 Receptor.

Xiaohua Li1,2, Guoxing Zhang3, Xia Cao4.   

Abstract

In addition to the key role in hemostasis and thrombosis, platelets have also been wildly acknowledged as immune regulatory cells and involving in the pathogenesis of inflammation-related diseases. Since purine receptor P2Y12 plays a crucial role in platelet activation, P2Y12 antagonists such as clopidogrel, prasugrel, and ticagrelor have been widely used in cardiovascular diseases worldwide in recent decades due to their potent antiplatelet and antithrombotic effects. Meanwhile, the role of P2Y12 in inflammatory diseases has also been extensively studied. Relatively, there are few studies on the regulation of P2Y12. This review first summarizes the various roles of P2Y12 in the process of platelet activation, as well as downstream effects and signaling pathways; then introduces the effects of P2Y12 in inflammatory diseases such as sepsis, atherosclerosis, cancer, autoimmune diseases, and asthma; and finally reviews the current researches on P2Y12 regulation.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Inflammation; P2Y12; P2Y12 antagonists; Platelet; Regulation

Year:  2021        PMID: 34319489     DOI: 10.1007/s10557-021-07229-4

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  177 in total

1.  ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999.

Authors:  F L Zhang; L Luo; E Gustafson; J Lachowicz; M Smith; X Qiao; Y H Liu; G Chen; B Pramanik; T M Laz; K Palmer; M Bayne; F J Monsma
Journal:  J Biol Chem       Date:  2000-12-04       Impact factor: 5.157

2.  The P2Y12 receptor regulates microglial activation by extracellular nucleotides.

Authors:  Sharon E Haynes; Gunther Hollopeter; Guang Yang; Dana Kurpius; Michael E Dailey; Wen-Biao Gan; David Julius
Journal:  Nat Neurosci       Date:  2006-11-19       Impact factor: 24.884

Review 3.  P2Y12 receptors: structure and function.

Authors:  M Cattaneo
Journal:  J Thromb Haemost       Date:  2015-06       Impact factor: 5.824

Review 4.  Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases.

Authors:  Jennifer Yeung; Wenjie Li; Michael Holinstat
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

5.  Identification of the platelet ADP receptor targeted by antithrombotic drugs.

Authors:  G Hollopeter; H M Jantzen; D Vincent; G Li; L England; V Ramakrishnan; R B Yang; P Nurden; A Nurden; D Julius; P B Conley
Journal:  Nature       Date:  2001-01-11       Impact factor: 49.962

6.  The platelet P2Y(12) receptor under normal and pathological conditions. Assessment with the radiolabeled selective antagonist [(3)H]PSB-0413.

Authors:  Philippe Ohlmann; Anna Lecchi; Ali El-Tayeb; Christa E Müller; Marco Cattaneo; Christian Gachet
Journal:  Purinergic Signal       Date:  2012-08-15       Impact factor: 3.765

7.  ADP receptor P2Y12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels.

Authors:  Anna-Karin Wihlborg; Lingwei Wang; Oscar Ostberg Braun; Atli Eyjolfsson; Ronny Gustafsson; Tomas Gudbjartsson; David Erlinge
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-08-12       Impact factor: 8.311

Review 8.  Platelets and Immune Responses During Thromboinflammation.

Authors:  Matthias Mezger; Henry Nording; Reinhard Sauter; Tobias Graf; Christian Heim; Nikolas von Bubnoff; Stephan M Ensminger; Harald F Langer
Journal:  Front Immunol       Date:  2019-07-26       Impact factor: 7.561

Review 9.  The Human Platelet as an Innate Immune Cell: Interactions Between Activated Platelets and the Complement System.

Authors:  Oskar Eriksson; Camilla Mohlin; Bo Nilsson; Kristina N Ekdahl
Journal:  Front Immunol       Date:  2019-07-10       Impact factor: 7.561

10.  Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance.

Authors:  Connie H Y Wong; Craig N Jenne; Björn Petri; Navina L Chrobok; Paul Kubes
Journal:  Nat Immunol       Date:  2013-06-16       Impact factor: 25.606

View more
  3 in total

1.  High-sensitivity C-reactive protein as a better predictor of post-thrombolytic functional outcome in patients with previous antiplatelet therapy.

Authors:  Tan Li; Qiannan Yu; Yiqing Wang; Xiuying Cai; Yan Kong; Hongru Zhao; Shanshan Diao; Yiren Qin; Qi Fang
Journal:  Eur J Med Res       Date:  2022-06-03       Impact factor: 4.981

2.  Combination of Colchicine and Ticagrelor Inhibits Carrageenan-Induced Thrombi in Mice.

Authors:  BuChun Zhang; Rong Huang; DaiGang Yang; GuiLan Chen; YuanLi Chen; Jihong Han; Shuang Zhang; LiKun Ma; XiaoXiao Yang
Journal:  Oxid Med Cell Longev       Date:  2022-01-17       Impact factor: 6.543

3.  Elevated serum C1q is an independent predictor of high residual platelet reactivity in CAD patients receiving clopidogrel therapy.

Authors:  Zehao Zhao; Meishi Ma; Xin Huang; Tienan Sun; Kangning Han; Shiwei Yang; Yujie Zhou
Journal:  Front Immunol       Date:  2022-09-30       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.